TTD | Drug: D00XOQ

Drug General Information
Drug ID	D00XOQ
Former ID	DNC004540
Drug Name	SB-210313
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[534804]
Structure		Download 2D MOL 3D MOL
Formula	C21H23FN4O
Canonical SMILES	C1COCCN1CCCN2C=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F
InChI	1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2
InChIKey	ANWALZPQHPAZFO-UHFFFAOYSA-N
PubChem Compound ID	9885504
Target and Pathway
Target(s)	Cytochrome P450 2D6	Target Info	Inhibitor	[534804]
KEGG Pathway	Metabolism of xenobiotics by cytochrome P450
	Drug metabolism - cytochrome P450
	Serotonergic synapse
Reactome	Xenobiotics
WikiPathways	Metapathway biotransformation
	Tamoxifen metabolism
	Oxidation by Cytochrome P450
	Vitamin D Receptor Pathway
	Aripiprazole Metabolic Pathway
	Fatty Acid Omega Oxidation
	Codeine and Morphine Metabolism
References
Ref 534804	Bioorg Med Chem Lett. 1998 Nov 17;8(22):3111-6.Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.
Ref 534804	Bioorg Med Chem Lett. 1998 Nov 17;8(22):3111-6.Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information